Laser treatment for pigmentary glaucoma
Part of Eyes & vision clinical trials.
This trial tests a laser procedure called DSLT to lower eye pressure in people with pigmentary glaucoma. It may offer a treatment option for those who have not had prior glaucoma surgeries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pigmentary glaucoma or pigment dispersion syndrome with high eye pressure
- Your eye pressure is between 18 and 34 mmHg after stopping any glaucoma drops
- Your cornea thickness is between 480 and 600 micrometers
- You are willing to stop your current glaucoma drops for a short time
- You have not had any glaucoma surgery or laser treatment in the study eye in the past 3 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a laser treatment called DSLT to see how it affects eye pressure changes over 6 months. It may help people with open-angle glaucoma or high eye pressure who are currently using 0 to 3 types of pressure-lowering eye drops.
This trial is testing a laser treatment called DSLT to see if it can help people with glaucoma use fewer eye drops. It may be a good option if your eye pressure is already controlled with medication and you haven't had glaucoma surgery before.
This trial tests a special laser treatment called Direct Selective Laser Trabeculoplasty (DSLT) for people with pseudoexfoliation glaucoma, a type of glaucoma that can be harder to treat. The treatment aims to lower eye pressure and may help delay or avoid the need for daily eye drops.
This study tests a newer type of laser treatment for glaucoma, called direct selective laser trabeculoplasty (DSLT), in people who have already had a standard SLT laser before. It aims to see if DSLT can further lower eye pressure, which may help protect your vision.
This trial tests a laser treatment called DSLT in people recently diagnosed with open-angle glaucoma who have never had any other glaucoma treatment. It aims to see how well the laser lowers eye pressure.
This trial tests a new laser treatment called DSLT for people with normal-tension glaucoma, a type of glaucoma where eye pressure is normal but vision is still damaged. It aims to lower eye pressure and help preserve vision. The study is specifically for people of Asian descent.
Hear when a new Pigmentary Dispersion Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.